Xilio Therapeutics, Inc.XLONASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank80
3Y CAGR+60.5%
5Y CAGR-0.9%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+60.5%/yr
Annual compound
5Y CAGR
-0.9%/yr
Recent acceleration
Percentile
P80
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.46 | +48.7% |
| 2023 | 0.31 | +64.8% |
| 2022 | 0.19 | +68.8% |
| 2021 | 0.11 | +102.7% |
| 2020 | -4.14 | -956.0% |
| 2019 | 0.48 | - |